Yuan, Q, Wang, Y, Song, R, Hou, X, Yu, K, Zheng, J, Zhang, J, Pu, X, Han, J and Zong, L (2019) Study on Formulation, in vivo Exposure, and Passive Targeting of Intravenous Itraconazole Nanosuspensions. Frontiers in Pharmacology, 10. 225 -225. ISSN 1663-9812

[thumbnail of fphar-10-00225.pdf]
fphar-10-00225.pdf - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview


The pharmacokinetic profile of a drug can be different when delivered as a nanosuspension compared with a true solution, which may in turn affect the therapeutic effect of the drug. The goal of this study was to prepare itraconazole nanosuspensions (ITZ-Nanos) stabilized by an amphipathic polymer, polyethylene glycol-poly(Benzyl aspartic acid ester), by the precipitation-homogenisation, and study the pharmacokinetic curve of the ITZ-Nanos. The particle size and morphology of nanosuspensions were assayed by Zetasizer and field emission scanning electron microscope (SEM), severally. The dissolution profile was evaluated using a paddle method according to Chinese Pharmacopoeia 2015. The level of ITZ in blood and tissues was measured by a HPLC method. The optimized ITZ-Nanos had a mean particle size of 268.1±6.5 nm and the particles were in a rectangular form. The dissolution profile of ITZ-Nanos resemble that of commercial ITZ injections, with nearly 90% ITZ released in the first five minutes. The ITZ-Nanos showed distinct pharmacokinetic properties compared with the commercial ITZ injections, including a reduced beginning drug concentration, enhanced t1/2 and MRT, and increased concentration in the liver, lung and spleen. The ITZ-Nanos can change the in vivo distribution of ITZ and result in passive targeting to the organs with mononuclear phagocyte systems.

Item Type: Article
Additional Information: This is the final published version of the article (version of record). It first appeared online via Frontiers Media at https://www.frontiersin.org/article/10.3389/fphar.2019.00225 - please refer to any applicable terms of use of the publisher.
Uncontrolled Keywords: itraconazole nanosuspension, process optimization, in vivo pharmacokinetics, tissue distribution, passive targeting
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Medicine and Health Sciences > School of Pharmacy
Depositing User: Symplectic
Date Deposited: 16 Apr 2019 14:36
Last Modified: 16 Apr 2019 15:09
URI: https://eprints.keele.ac.uk/id/eprint/6193

Actions (login required)

View Item
View Item